Feb 12, 2020 / 01:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by. And welcome to the fourth quarter and full year 2019 financial results. (Operator Instructions) I must advice you the call is being recorded today, 12 February 2020.
I would now like to hand the conference over to your first speaker today, Kevin Mannix, Senior Vice President, Head of Teva Investor Relations. Please go ahead.
Kevin C. Mannix - Teva Pharmaceutical Industries Limited - SVP of IR
Thank you, Steve, and thank you, everyone, for joining us today to discuss Teva's fourth quarter and full year 2019 financial results. We hope you've had an opportunity to review our very detailed earnings press release, which was issued earlier this morning. A copy of the release as well as a copy of the slides being presented on this call can be found on our website at www.tevapharm.com as well as through our Teva Investor Relations app.
Please note that the discussion on today's call includes certain non-GAAP measures as defined by the SEC
Q4 2019 Teva Pharmaceutical Industries Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot